Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
European Myeloma Network B.V.
Northside Hospital, Inc.
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
USWM, LLC (dba US WorldMeds)
City of Hope Medical Center
Shanghai Jiao Tong University School of Medicine
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of Washington
Mayo Clinic
National Cancer Institute, Egypt
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Turin, Italy
M.D. Anderson Cancer Center
Yale University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Genmab
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Henan Cancer Hospital
Memorial Sloan Kettering Cancer Center
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
University of Washington
University College, London
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
Milton S. Hershey Medical Center
Alliance for Clinical Trials in Oncology
Guangdong Provincial People's Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dana-Farber Cancer Institute
Canadian Cancer Trials Group